Home » Topics » Regulatory » NMPA

NMPA
RSS

Cervarix approved in China

July 18, 2016

CFDA approves Roche's CINtec PLUS Cytology test

March 9, 2016

3SBio obtains IND clearance in China for PEG-irinotecan

March 7, 2016

Tapros approved for open-angle glaucoma and ocular hypertension in China

Aug. 26, 2015

CFDA approves phase I/II/III clinical trials of pirotinib

Aug. 14, 2015

China Food and Drug Administration accepts clinical trial application for sirotinib

July 16, 2015

Phase II trials of F-351 begin in China

June 12, 2015

Arteether amine maleate cleared to enter clinical studies in China

May 26, 2015

China FDA clears IND for development of DP-VPA through phase III for epilepsy

April 16, 2015

China approves Epidaza for peripheral T-cell lymphoma

Jan. 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...